Summary.
Methotrexate (MTX) is a folate antagonist used in treatment of several chronic inflammatory and neoplastic conditions. In this study, new MTX-like compounds that may-be potential anticancer agents were synthesized and their structures were determined by IR, UV, GC-MS, 1H NMR, and 13C NMR spectra. Also, in this study, a series structurally related to MTX or folate analogous compounds were evaluated whether they have inhibitory properties on the dihydrofolate reductase activity (DHFR).
Similar content being viewed by others
References
VM Whitehead MM Perrault S Stelcner (1975) Cancer Res 35 2985 Occurrence Handle1:CAS:528:DyaE28Xht1GjtQ%3D%3D
S Farber LK Damond RD Mercer RF Sylvester JA Wolf (1948) New England J Med 238 787 Occurrence Handle1:CAS:528:DyaH1cXjt1Chtg%3D%3D Occurrence Handle10.1056/NEJM194806032382301
JD Borsi E Sagen I Romslo PJ Moe (1990) Pediatr Hematol Oncol 7 13 Occurrence Handle10.3109/08880019009033412 Occurrence Handle1:STN:280:DyaK3czntlKguw%3D%3D
AL Franklin M Belt ELR Stokstad TH Jukes (1949) J Biol Chem 177 621 Occurrence Handle1:CAS:528:DyaH1MXitVejsw%3D%3D
WA Blayer (1978) Cancer 41 36 Occurrence Handle10.1002/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO;2-I
DE Furst (1985) J Rheumatol 12 IssueID12 11
DE Furst JM Kremer (1988) Arthritis Rheum 31 305 Occurrence Handle10.1002/art.1780310301 Occurrence Handle1:STN:280:DyaL1c7pt1Oiuw%3D%3D
MJ Boffa RJ Chalmers (1996) Clin Exp Dermatol 21 IssueID6 399 Occurrence Handle10.1111/j.1365-2230.1996.tb00142.x Occurrence Handle1:STN:280:DyaK2szhtVSitw%3D%3D
PA Anderson SA West JR O’Dell CS Vi G Claypool BL Katxin (1985) Ann Int Med 103 489
DE Furst JM Kremer (1988) Arthritis Rheum 31 305 Occurrence Handle10.1002/art.1780310301 Occurrence Handle1:STN:280:DyaL1c7pt1Oiuw%3D%3D
HH Roenick HI Maibach G Weinstein (1972) Arch Dermatol 105 363 Occurrence Handle10.1001/archderm.105.3.363
T Ternowitz P Bjerring PH Anderson JM Schroeder K Kragballe (1987) J Invest Dermatol 89 192 Occurrence Handle10.1111/1523-1747.ep12470559 Occurrence Handle1:STN:280:DyaL2s3lt1eluw%3D%3D
MF Mullarkey DR Webb NE Pardee (1986) Ann Allergy 56 347 Occurrence Handle1:STN:280:DyaL287osVOqsA%3D%3D
MF Mullarkey BA Blumenstein WP Andrade GA Bailey I Olason CE Wetzel (1988) New England J Med 318 603 Occurrence Handle1:STN:280:DyaL1c7ktlSjtw%3D%3D Occurrence Handle10.1056/NEJM198803103181004
T Jeffrey DO Kırchner (1998) Am Fam Physician 15 IssueID4 817
J Jolivet KH Cowan GA Curt NJ Clendeninn BA Chabner (1983) New England J Med 309 1094 Occurrence Handle1:CAS:528:DyaL3sXmtVGnsrs%3D Occurrence Handle10.1056/NEJM198311033091805
KS Basin A Escalante TD Beardmore (1991) J Rheumatol 18 609 Occurrence Handle1:STN:280:DyaK3M3psFWitQ%3D%3D
HN Alkaya AM Gharaibeh MAS Salem (1990) Ther Drug Monit 12 191 Occurrence Handle10.1097/00007691-199003000-00014
Qianshun Y, Jinsong Y, Qingxiang X, Xiaoqi Y, Rugang X (2001) Huaxue Yanjiu Yu Yingyong 13(2): 189; (2002) Chem Abstr 136: 263409z
Nigel IH, Timothy DHB (2004) Bioorg Med Chem 11(14): 3083; (2003) Chem Abstr 140: 42442k
Kudryashova VV, Dikovskaya KI, Kalnins A, Kropivets LS, Freimanis J, Sakhartova OV, Turovskii IV (1988) Inst Org Synth Riga USSR. Bioorganicheskaya Khimiya 14(2): 216; Chem Abstr 109: 110073c
P Maunder MF Paul IM Anthony A Fred M Mellon R Aaqib R Brian V Liisa W Cornelia (1999) J Chem Soc Perkin Trans 1 1311 Occurrence Handle10.1039/a900944b
EJ Pastore LT Plante RL Kisliuk (1974) Methods Enzymol 34 281 Occurrence Handle1:CAS:528:DyaE2MXkt1Cjs7s%3D Occurrence Handle10.1016/S0076-6879(74)34026-8
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Çolak, N., Yıldırır, Y., Kavutcu, M. et al. The Synthesis of Novel Methotrexate-like Compounds. Monatsh. Chem. 138, 1283–1287 (2007). https://doi.org/10.1007/s00706-007-0716-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-007-0716-0